SEARCH RESULT

Total Matching Records found : 88

Made for Big Pharma -Paranjoy Guha Thakurta

-Deccan Chronicle Prime Minister Narendra Modi may be patting himself on the back because President Barack Obama has agreed to India's position on food stockholding norms in World Trade Organisation (WTO). However, New Delhi seems to be bending over backwards to accommodate the American government and giant multinational corporations (MNCs) in the pharmaceutical industry, which will work to the detriment of our country's interests. In less than six months, the Modi government...

More »

What is novelty? -Rajshree Chandra

-The Indian Express The era of globalised markets is also an era of globalised sovereignties. Nation states must constantly sync their policies with global constituencies of policies and citizens. At times, domestic disharmony is the price nation states may be required and willing to pay. The case in point here is the proposed review of the intellectual property rights (IPR) policy, particularly those clauses that are related to pharmaceutical patent policy....

More »

New drug era -Shamnad Basheer

-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...

More »

Pharma pricing norms set to be tightened -Sushmi Dey

-The Business Standard   Regulator studying pricing models in various nations; draft legislation likely by end of March Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries. The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market,...

More »

Activists demand access to affordable oral hepatitis drugs

-Down to Earth Giving patents to foreign-made medicines will add to patients' woes, they urge Health activists staged a protest in front of the office of Union Ministry of Health and Family Welfare on Friday, demanding that the government should ensure that oral drugs to treat Hepatitis C are made available to patients. The demonstrators were later assured by the ministry officials that they would look into the matter...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close